The Pharmaceutical Journal
Vol 280 No 7492 p269
8 March 2008

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Genomic medicine risks and benefits to be looked at by Lords

Potential benefits and risks of genomic medicines are to be examined by a parliamentary subcommittee.

The House of Lords Science and Technology Committee has appointed a sub-committee to assess the actual and potential impact of genome technologies on clinical practice. The subcommittee will consider who currently monitors developments, provides advice and develops policy in this area, as well as whether regulatory gaps exist.

It will also look at what impact genomic information will have on the classification of disease and on individualised medical advice.

Further details of the inquiry are available online. The closing date for submitting written evidence is 21 April 2008.